ライフサイエンスコーパス: cardiac pacing

1 enerator could represent a paradigm shift in cardiac pacing.

2 are common or controversial indications for cardiac pacing.

3 ), contributes significantly to neuronal and cardiac pacing.

4 ted by hyperpolarization, is a key player in cardiac pacing.

5 rome causes syncope, and symptoms respond to cardiac pacing.

6 cardiomyopathy despite early institution of cardiac pacing.

7 be transferred to the capital for temporary cardiac pacing.

8 , metabolic vasodilation was assessed during cardiac pacing.

9 ber pacemakers for most patients who require cardiac pacing.

10 ker replacement or a complication related to cardiac pacing.

11 atural history of heart failure due to rapid cardiac pacing.

12 s not necessarily imply a permanent need for cardiac pacing.

13 pacemakers and the termination of long-term cardiac pacing.

14 valuation of the methods and indications for cardiac pacing.

15 One group of dogs underwent 4 weeks of cardiac pacing (210 bpm for 3 weeks and 240 bpm during w

16 CHF was then induced by chronic rapid cardiac pacing and characterized by impaired cardiac fun

17 Implantable cardiac pacing and defibrillation devices are effective

18 th combined therapy consisting of continuous cardiac pacing and maximally tolerated beta-blocker ther

19 Rabbits with chronic cardiac pacing and sham operation were randomized to rec

20 Sympathetic nerve activity decreased with cardiac pacing and the decline was greater with AV than

21 Arterial pressure increased with cardiac pacing and was greater with AV than with ventric

22 dications for ICD therapy, no indication for cardiac pacing, and an LVEF of 40% or less, dual-chamber

23 only contribute to a better understanding of cardiac pacing but also may advance current efforts that

24 As expected, cardiac pacing eliminated beat-to-beat RR interval varia

25 The efficacy of cardiac pacing for prevention of syncopal recurrences in

26 A rethinking of the physiology of cardiac pacing has led to the concept that although atri

27 New indications for permanent cardiac pacing have been developed in recent years, with

28 ble, and expanding clinical use of permanent cardiac pacing in a number of these conditions or syndro

29 e benefits and appropriate uses of permanent cardiac pacing in a variety of pathophysiologic states o

30 We sought to determine the incidence of cardiac pacing in our cardiac transplant population and

31 Prevention of syncope through permanent cardiac pacing in patients with bifascicular block (PRES

32 Indications for cardiac pacing in pediatric patients continue to expand.

33 ease and enabling beat-to-beat adaptation of cardiac pacing in response to physiological feedback.

34 In contrast, cardiac pacing in the 40 degree tilt position increased

35 Against expectations, however, cardiac pacing in the supine position significantly redu

36 ts with syncope of unknown origin, selecting cardiac pacing in those with a positive ATP test leads t

37 Rapid cardiac pacing increased myocardial oxidative stress as

38 Cardiac pacing-induced epicardial constriction was aboli

39 Cardiac pacing-induced reduction in coronary vascular re

40 Cardiac pacing is an effective treatment for patients wi

41 Cardiac pacing is effective for those patients with seve

42 electrode position for long-term transvenous cardiac pacing is in the apex of the right ventricle.

43 Cardiac pacing is poised to help millions of patients wo

44 ment of atrioventricular block, dual-chamber cardiac pacing is thought to confer a clinical benefit a

45 If or Ih, a key player in neuronal and cardiac pacing, is encoded by the hyperpolarization-acti

46 ormally functioning hearts and stimulated by cardiac pacing; it thus functioned as an ideal therapeut

47 Discontinuation of cardiac pacing may be considered in certain patients.

48 nts with predominantly AF and secondary SND, cardiac pacing may be the mainstay of therapy for patien

49 icular outflow gradient at rest suggest that cardiac pacing may result in symptomatic and hemodynamic

50 han does ventricular pacing, indicating that cardiac pacing mode may influence sympathetic outflow si

51 Metabolic vasodilation was assessed during cardiac pacing (n = 19).

52 oventricular nodal disease, applications for cardiac pacing now include treatment of tachyarrhythmias

53 t pacemaker is increasing, but the effect of cardiac pacing on long-term survival and functional vari

54 by partial reduction of coronary flow, rapid cardiac pacing, or brief ischemia-reperfusion of a remot

55 esuscitation, defibrillation, cardioversion, cardiac pacing, or treatments targeted at the underlying

56 Better prediction of cardiac pacing patients at risk of atrial fibrillation (

57 ation of similar patients and affect present cardiac-pacing policies.

58 We elected to use cardiac pacing rather than chronotropic drugs to minimiz

59 he aim of the study was to determine whether cardiac pacing reduces falls in older adults with cardio

60 Permanent cardiac pacing remains the only effective treatment for

61 Leadless cardiac pacing represents the future of cardiac pacing s

62 Dual-chamber AV cardiac pacing results in greater cardiac output and low

63 s, methods, and timing of the termination of cardiac pacing seems appropriate.

64 Despite early institution of cardiac pacing, some infants with CHB develop LV cardiom

65 These results suggest that high cardiac pacing stochasticity is likely to reduce the ris

66 less cardiac pacing represents the future of cardiac pacing systems, similar to the transition that o

67 ore amiodarone recipients required temporary cardiac pacing than did recipients of lidocaine or place

68 We used cardiac pacing to test the hypothesis that CM evolution

69 Cardiac pacing was effective in neurally mediated syncop

70 on Syncope of Uncertain Etiology (ISSUE-3), cardiac pacing was effective in reducing recurrence of s

71 The most common indication for cardiac pacing was permanent atrial fibrillation with at

72 dial diameter response to Ach, adenosine and cardiac pacing were measured in 32 patients with coronar

73 Four pairs of cardiac pacing wires were implanted on the serosa of the